Your browser doesn't support javascript.
Changes of peripheral lymphocyte subset in patients with SARS-CoV-2 infection during the whole course of disease.
Yu, Xingxia; Yang, Rongrong.
  • Yu X; Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, China.
  • Yang R; Department of Infectious Diseases, Zhongnan Hospital, Wuhan University, Wuhan, China.
Expert Rev Respir Med ; 15(4): 553-559, 2021 04.
Article in English | MEDLINE | ID: covidwho-1003460
ABSTRACT

Background:

Little is known about changes in lymphocyte subsets after SARS-CoV-2 infection.

Methods:

Clinical data of 580 COVID-19 patients hospitalized in Zhongnan Hospital of Wuhan University from 20 December 2019, to 8 March 2020, were retrospectively analyzed. The relation of lymphocyte subsets and severity or prognosis of disease were analyzed.

Results:

At 2-3 weeks after the onset of symptoms, lymphocyte subsets decreased to the lowest levels. The levels of lymphocyte subsets in asymptomatic patients were close to healthy persons, except for CD8+ T lymphocyte cells. The levels of lymphocyte subsets in patients with severe illness were lower than that in patients with mild-to-moderate illness (P < 0.01). Similarly, among patients with severe illness, lower levels of lymphocyte subsets were found in dead patients compared to survivors (P < 0.001). Moreover, by comparing the results of the same patients at different stages of the disease, we found levels of lymphocyte subsets were lower in the acute phase compared to that in convalescent-phase (P < 0.001). However, the levels of lymphocyte subsets in patients who had SARS-CoV-2 viral load >5000 copies/ml and 500-5000 copies/ml were at similar levels.

Conclusions:

Lymphocyte subsets are a good biomarker to assess the severity and prognosis of the disease at 2-3 weeks after the onset of symptoms.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphocyte Subsets / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Expert Rev Respir Med Year: 2021 Document Type: Article Affiliation country: 17476348.2021.1866991

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphocyte Subsets / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Expert Rev Respir Med Year: 2021 Document Type: Article Affiliation country: 17476348.2021.1866991